<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="53575">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01818531</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00023002</org_study_id>
    <nct_id>NCT01818531</nct_id>
  </id_info>
  <brief_title>Adductor Canal Block for Medial Compartment Knee Arthroplasty</brief_title>
  <official_title>Evaluation of Ultrasound-Guided Adductor Canal Blockade for Postoperative Analgesia Following Robotic Medial Unicompartmental Knee Replacement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest Baptist Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wake Forest Baptist Health</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the affects of a single injection ultrasound-guided adductor canal
      block for patients undergoing robotic-assisted (MAKOplasty) medial UKA (unicompartmental
      knee arthroplasty).  Specifically, this study will compare the adequacy of postoperative
      analgesia provided by the adductor canal block with that provided by single injection lumbar
      plexus blockade.  The working hypothesis is that the analgesia provided by the adductor
      canal block will be equivalent to the analgesia provided by the lumbar plexus block.  The
      primary outcome will be a comparison of verbal numerical pain scores at rest and with
      movement over the first 24 hours following nerve blockade.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">April 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Verbal pain scores at 6 hours post nerve blockade.</measure>
    <time_frame>6 hours post block.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Comparison of verbal numerical pain scores at rest and with movement over the first 24 hours following nerve blockade.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Opioid consumption</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Comparison of opioid consumption over 24 hour period between adductor canal block and lumbar plexus block.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first analgesic</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Time to first analgesic between two groups: adductor canal block and lumbar plexus block.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid related side effects</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Occurrence of opioid related side effects (nausea, vomiting and itching) between two groups: adductor canal block and lumbar plexus block.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quadriceps motor strength</measure>
    <time_frame>6 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Comparison of quadriceps motor strength at 6 hour post nerve block between two groups: adductor canal block and lumbar plexus block.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Postoperative Analgesia</condition>
  <condition>Medial Unicompartmental Knee Arthroplasty</condition>
  <arm_group>
    <arm_group_label>Adductor canal block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this arm will receive an adductor canal block prior to undergoing a medial compartment knee arthroplasty.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lumbar plexus block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this arm will receive a lumbar plexus block prior to undergoing a medial compartment knee arthroplasty.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Adductor canal block</intervention_name>
    <arm_group_label>Adductor canal block</arm_group_label>
    <other_name>Saphenous nerve block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Lumbar plexus block</intervention_name>
    <arm_group_label>Lumbar plexus block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged 18-85

          -  Undergoing unilateral robotic-assisted (MAKOplasty) medial compartment knee
             arthroplasty at Wake          Forest University Baptist Medical Center.

          -  Must give written informed consent for anesthesia including subarachnoid blockade and
             peripheral nerve blockade of both the lumbar plexus and adductor canal.

          -  Must consent to the performance of a sham block at the site to which they are not
             randomized.

          -  Must also be reliable to give accurate verbal pain scores postoperatively.

        Exclusion Criteria:

          -  Contraindication to adductor canal blockade or lumbar plexus blockade (including
             significant coagulation abnormalities)

          -  History of opioid addiction or current chronic pain therapy for pain other than at
             the surgical site that is being treated with high-dose opioids (extended release
             opioids or &gt; 40mg oxycodone equivalents per day)

          -  Allergy to study medications

          -  Failure to adequately place either the adductor canal or lumbar plexus blocks.

          -  Patients who decline or have a contraindication to subarachnoid blockade will also be
             excluded from the study.

          -  Pregnancy.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daryl S Henshaw, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wake Forest Baptist Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Daryl S Henshaw, MD</last_name>
    <phone>3367164498</phone>
    <email>dhenshaw@wakehealth.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Wake Forest University Baptist Medical Center</name>
      <address>
        <city>Winston Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daryl S Henshaw, MC</last_name>
      <phone>336-716-4498</phone>
      <email>dhenshaw@wakehealth.edu</email>
    </contact>
    <investigator>
      <last_name>Daryl S Henshaw, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert Weller, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Douglas Jaffe, DO</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>James Crews, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jon Reynolds, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Meek RM, Masri BA, Duncan CP. Minimally invasive unicompartmental knee replacement: rationale and correct indications. Orthop Clin North Am. 2004 Apr;35(2):191-200. Review.</citation>
    <PMID>15062705</PMID>
  </reference>
  <reference>
    <citation>Riddle DL, Jiranek WA, McGlynn FJ. Yearly incidence of unicompartmental knee arthroplasty in the United States. J Arthroplasty. 2008 Apr;23(3):408-12. doi: 10.1016/j.arth.2007.04.012. Epub 2007 Nov 26.</citation>
    <PMID>18358380</PMID>
  </reference>
  <reference>
    <citation>Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007 Apr;89(4):780-5.</citation>
    <PMID>17403800</PMID>
  </reference>
  <reference>
    <citation>GARDNER E. The innervation of the knee joint. Anat Rec. 1948 May;101(1):109-30.</citation>
    <PMID>18915634</PMID>
  </reference>
  <reference>
    <citation>Davis JJ, Bond TS, Swenson JD. Adductor canal block: more than just the saphenous nerve? Reg Anesth Pain Med. 2009 Nov-Dec;34(6):618-9. doi: 10.1097/AAP.0b013e3181bfbf00.</citation>
    <PMID>19901788</PMID>
  </reference>
  <reference>
    <citation>Horner G, Dellon AL. Innervation of the human knee joint and implications for surgery. Clin Orthop Relat Res. 1994 Apr;(301):221-6.</citation>
    <PMID>8156678</PMID>
  </reference>
  <reference>
    <citation>Jenstrup MT, Jæger P, Lund J, Fomsgaard JS, Bache S, Mathiesen O, Larsen TK, Dahl JB. Effects of adductor-canal-blockade on pain and ambulation after total knee arthroplasty: a randomized study. Acta Anaesthesiol Scand. 2012 Mar;56(3):357-64. doi: 10.1111/j.1399-6576.2011.02621.x. Epub 2012 Jan 4. PubMed PMID: 22221014.</citation>
    <PMID>22221014</PMID>
  </reference>
  <reference>
    <citation>Lund J, Jenstrup MT, Jaeger P, Sørensen AM, Dahl JB. Continuous adductor-canal-blockade for adjuvant post-operative analgesia after major knee surgery: preliminary results. Acta Anaesthesiol Scand. 2011 Jan;55(1):14-9. doi: 10.1111/j.1399-6576.2010.02333.x. Epub 2010 Oct 29.</citation>
    <PMID>21039357</PMID>
  </reference>
  <reference>
    <citation>Farrar JT, Berlin JA, Strom BL. Clinically important changes in acute pain outcome measures: a validation study. J Pain Symptom Manage. 2003 May;25(5):406-11.</citation>
    <PMID>12727037</PMID>
  </reference>
  <reference>
    <citation>Schuirmann DJ. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm. 1987 Dec;15(6):657-80.</citation>
    <PMID>3450848</PMID>
  </reference>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 28, 2013</lastchanged_date>
  <firstreceived_date>March 21, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wake Forest University Baptist Medical Center</investigator_affiliation>
    <investigator_full_name>Daryl Steven Henshaw, MD</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Partial knee replacement</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
